Gall Matthew — insider trades
Stock trades Gall Matthew reported on SEC Form 4 at ITOS iTeos Therapeutics, Inc..
- Nov 19, 2024: bought 5,000 shares of ITOS iTeos Therapeutics, Inc. ($38.7K)
Stock trades Gall Matthew reported on SEC Form 4 at ITOS iTeos Therapeutics, Inc..